C9orf72 and amyotrophic lateral sclerosis: Whilst we believe that BRAFi should be subjected to further pre-clinical investigation as a generalized therapy for ALS, these data suggest that further specific investigation of the interplay between C9orf72 and BRAF signalling is warranted.